Specialized Correctional Facility Healthcare Provider
Correctional Healthcare Provider in the Rocky Mountain Region
On NextCompany since September 30, 2026 (15 days)
Location undisclosed
Business overview
This provider delivers on-site gastrointestinal care at correctional facilities across the Rocky Mountain region. It performs diagnostic, consultative, and therapeutic procedures for incarcerated people. Contracts with third-party administrators generate repeat revenue, and on-site care eliminates inmate transportation costs. The business reports $1,795,156 in gross revenue and $793,506 in EBITDA. Its adjusted EBITDA margin averaged 39.0% during 2022-2025.
Growth opportunities include neighboring states and collaboration with other medical specialties. An affiliated entity owns the 1,900 sq. ft. administrative office and offers an assumable lease. The single shareholder seeks a buyer who can contribute to growth and wishes to remain in management after the sale.
Who is a good fit for this business
- Healthcare operators seeking to provide on-site gastrointestinal services to federal, state, and local correctional facilities.
- Strategic healthcare acquirers seeking expansion into neighboring states or collaboration with other medical specialties.
Details
- Reason for selling
- The single shareholder seeks a buyer that can capitalize on and contribute to future growth and wishes to remain in management post-sale.
- Real estate
- Leased
Frequently Asked Questions
The provider delivers on-site gastrointestinal diagnostic, consultative, and therapeutic procedures for incarcerated people. It serves federal, state, and local correctional facilities in the Rocky Mountain region.
The business reports $1,795,156 in gross revenue and $793,506 in EBITDA. Its adjusted EBITDA margin averaged 39.0% during 2022-2025.
An affiliated entity owns the 1,900 sq. ft. administrative office and excludes it from the sale. The entity offers an assumable lease, and the business can relocate.
The single shareholder seeks a buyer who can contribute to future growth. The shareholder also wishes to remain in management after the sale.